Bristol Myers Squibb

Top Company Values

Set Carbon Neutrality Target

Pioneering a Green Future with a 2040 Carbon Neutrality Target.

In the current era of heightened environmental awareness, Bristol Myers Squibb has responded by setting a future-shaping target: to become carbon neutral by 2040. This is no simple task, and it represents a concerted commitment to reduce their carbon footprint and prioritize sustainable practices in all areas of operation.

Embracing this mission has led Bristol Myers Squibb to thoroughly assess and reconfigure their energy practices. Investment in energy-efficient infrastructure and initiatives has become a cornerstone of this process. The company is in the process of upgrading facilities and operational systems to incorporate cutting-edge, energy-saving technologies that align with their 2040 carbon neutrality goal.

Bristol Myers Squibb is also leveraging renewable energy sources to power its operations. The company has adopted a pro-solar stance, installing solar panels in many of its facilities. Furthermore, it has entered into power purchase agreements with providers of renewable energy. By sourcing its power in this way, Bristol Myers Squibb is reducing reliance on fossil fuels and stimulating the renewable energy sector.

The company's commitment to this environmental cause transcends its own corporate boundaries. Bristol Myers Squibb actively advocates for environmental responsibility within the broader pharmaceutical industry. Participating in industry forums and partnerships, they are a force for the propagation of sustainable practices, intent on driving positive changes that extend far beyond their own operations.

Bristol Myers Squibb also focuses on its external relationships, holding its suppliers to the same high standard of environmental responsibility. The company provides tools and resources to suppliers, helping them to adopt and improve sustainable practices. This ensures that Bristol Myers Squibb’s commitment to reaching carbon neutrality by 2040 echoes throughout its entire supply chain, amplifying the potential impact on global sustainability efforts.

Published modern slavery statement

Upholding Ethical Practices and Championing Human Rights Against Modern Slavery.

In today's global society, corporate responsibility extends far beyond the business's immediate environment. Bristol Myers Squibb understands this and has taken tangible steps to address the critical global issue of modern slavery. The company has publicly announced a modern slavery statement, making a firm commitment to combat this issue in all forms throughout its operations.

The published modern slavery statement serves as the company's promise to operate with the highest ethical standards, vowing to eliminate any forms of forced labor, human trafficking, or other instances of modern slavery within its operation. They've integrated this commitment into the heart of their business model and everyday activities, ensuring that their work is always conducted with integrity and respect for human rights.

To enforce this commitment, Bristol Myers Squibb has implemented robust measures. These include comprehensive risk assessments and audits of their operations and suppliers, strict enforcement of policies against forced labor, and ongoing training for employees about modern slavery risks. Every staff member, from the top executives to entry-level employees, is well-informed and equipped to identify and address any possible violations.

Moreover, Bristol Myers Squibb maintains an open line of communication with its suppliers regarding its commitment against modern slavery. The company works diligently to ensure its suppliers not only understand Bristol Myers Squibb's stance but also share in its commitment to eradicate modern slavery. The company expects all partners to operate ethically and humanely, and encourages them to report any concerns or breaches of policy.

Actively manages ethical and sustainability standards in its supply chain

Ensuring Ethical and Sustainable Supply Chains for a Healthier Future.

In an industry that plays such a vital role in public health, ethical and sustainable practices aren't just nice-to-haves, they're non-negotiables. Bristol Myers Squibb (BMS) have made it an operational priority to actively manage ethical and sustainability standards within their supply chain.

A central part of BMS's commitment to sustainability and ethical responsibility lies in its robust vendor management program. This program not only screens potential suppliers for adherence to quality, environmental, and social standards but also regularly reviews the performance of current suppliers. It's a system that rewards ongoing compliance and discourages lapses in ethical business practices.